Home › Funds › Vivo Capital, LLC › ANIX

Vivo Capital, LLC position in ANIX

ANIXA BIOSCIENCES · Health Care

Vivo Capital, LLC reported holding 877,020 shares of ANIX (ANIXA BIOSCIENCES) in its Q3 2026 13F filing — a position valued at US$28.1M, representing 3.19% of its reported portfolio and ranking #12 among its reported holdings. Vivo Capital, LLC first reported this position in Q3 2026.

Latest position (Q3 2026)877.02K sh
Reported value held$28.06M
Portfolio Weight3.19%
First reportedQ3 2026
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vivo Capital, LLC's ANIX position evolved

Vivo Capital, LLC first disclosed a stake in ANIX in Q3 2026 at 877,020 shares (US$28.1M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 877.02K $28.06M New

About ANIX and 13F data

ANIX (ANIXA BIOSCIENCES) is a Health Care company. 36 other funds we track also report a position in ANIX — the largest reported positions include Sanofi (US$63.8M), Remedium Capital Partners, LLC (US$16.6M), Kalehua Capital Management LLC (US$14.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANIX

All ANIX fund holders →

FAQ

How long has Vivo Capital, LLC held ANIX?

Vivo Capital, LLC has disclosed ANIX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Vivo Capital, LLC's current position in ANIX?

As of Q3 2026, Vivo Capital, LLC holds 877.02K shares of ANIX (ANIXA BIOSCIENCES), valued at $28.06M, representing 3.19% of its reported portfolio and ranking #12.

Has Vivo Capital, LLC been buying or selling ANIX?

In the latest 13F filing (Q3 2026), Vivo Capital, LLC newly opened its position in ANIX.

Which other funds hold ANIX?

Other major institutional holders of ANIX include Sanofi, Remedium Capital Partners, LLC, Kalehua Capital Management LLC, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.